SCHEMBL7797903

SCHEMBL7797903

CCOc1cc(OCC)c(CO)cc1Br

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.43
HSD17B10 Q99714 2/20 0.43
LMNA P02545 3/20 0.41
CYP3A4 P08684 1/20 0.39
ALDH1A1 P00352 2/20 0.38
MAPT P10636 3/20 0.38
HPGD P15428 2/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
NCOA1 Q15788 1/20 0.37
NCOA3 Q9Y6Q9 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.37
MAPK1 P28482 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23586689 0.85 TSHR (0.41) TSHRHSD17B10LMNAALDH1A1MAPT
SCHEMBL7791974 0.85 HSD17B10 (0.34) TSHRHSD17B10LMNAALDH1A1MAPT
SCHEMBL20562654 0.80 HSD17B10 (0.44) TSHRHSD17B10LMNAALDH1A1MAPT
SCHEMBL10967724 0.79 LMNA (0.57) TSHRHSD17B10LMNACYP3A4ALDH1A1
SCHEMBL23459665 0.77 TSHR (0.53) TSHRHSD17B10LMNACYP3A4ALDH1A1
SCHEMBL5003240 0.77 MAPK1 (0.43) TSHRHSD17B10LMNAALDH1A1MAPT
SCHEMBL23459205 0.76 MAPT (0.39) HSD17B10LMNAALDH1A1MAPTHPGD
SCHEMBL23326296 0.76 LMNA (0.52) TSHRHSD17B10LMNACYP3A4MAPT
SCHEMBL4696548 0.76 HTR2A (0.52) ALDH1A1HTR2AHTR2C
SCHEMBL29775469 0.76 LMNA (0.52) TSHRHSD17B10LMNACYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010025045-A1 Substituted isoquinoline derivatives and their use as anticonvulsants SMITHKLINE BEECHAM P.L.C. 2001-09-27 US disclosed
EP-1025087-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2000-08-09 EP disclosed
WO-1999021836-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 1999-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010025045-A1 Substituted isoquinoline derivatives and their use as anticonvulsants INA, GRIN2C, GRIN2A TSHR 4289/4885HSD17B10 1492/4885LMNA 3590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.